| Year |
Citation |
Score |
| 2013 |
Hautz T, Krapf C, Grahammer J, Zelger B, Hickethier T, Seger C, Eberhart N, Wallner C, Messner F, Kotsch K, Griesmacher A, Brandacher G, Lee WP, Margreiter R, Pratschke J, ... Glossmann H, et al. Targeting the Kv1.3 potassium channel for immunosuppression in vascularized composite allotransplantation - a pilot study. Transplant International : Official Journal of the European Society For Organ Transplantation. 26: 552-61. PMID 23489391 DOI: 10.1111/Tri.12080 |
0.305 |
|
| 2005 |
Laggner C, Schieferer C, Fiechtner B, Poles G, Hoffmann RD, Glossmann H, Langer T, Moebius FF. Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening. Journal of Medicinal Chemistry. 48: 4754-64. PMID 16033255 DOI: 10.1021/Jm049073+ |
0.333 |
|
| 2003 |
Wolf M, Eberhart A, Glossmann H, Striessnig J, Grigorieff N. Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy. Journal of Molecular Biology. 332: 171-82. PMID 12946355 DOI: 10.1016/S0022-2836(03)00899-4 |
0.645 |
|
| 2003 |
Moebius FF, Fitzky BU, Wietzorrek G, Haidekker A, Eder A, Glossmann H. Cloning of an emopamil-binding protein (EBP)-like protein that lacks sterol delta8-delta7 isomerase activity. The Biochemical Journal. 374: 229-37. PMID 12760743 DOI: 10.1042/Bj20030465 |
0.361 |
|
| 2002 |
Wappl E, Koschak A, Poteser M, Sinnegger MJ, Walter D, Eberhart A, Groschner K, Glossmann H, Kraus RL, Grabner M, Striessnig J. Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. The Journal of Biological Chemistry. 277: 6960-6. PMID 11742003 DOI: 10.1074/Jbc.M110948200 |
0.707 |
|
| 2001 |
Koschak A, Reimer D, Huber I, Grabner M, Glossmann H, Engel J, Striessnig J. alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. The Journal of Biological Chemistry. 276: 22100-6. PMID 11285265 DOI: 10.1074/Jbc.M101469200 |
0.704 |
|
| 2001 |
Wappl E, Mitterdorfer J, Glossmann H, Striessnig J. Mechanism of dihydropyridine interaction with critical binding residues of L-type Ca2+ channel alpha 1 subunits. The Journal of Biological Chemistry. 276: 12730-5. PMID 11278630 DOI: 10.1074/Jbc.M010164200 |
0.665 |
|
| 2000 |
Kitaichi K, Chabot JG, Moebius FF, Flandorfer A, Glossmann H, Quirion R. Expression of the purported sigma(1) (sigma(1)) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. Journal of Chemical Neuroanatomy. 20: 375-87. PMID 11207432 DOI: 10.1016/S0891-0618(00)00106-X |
0.312 |
|
| 2000 |
Huber I, Wappl E, Herzog A, Mitterdorfer J, Glossmann H, Langer T, Striessnig J. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. The Biochemical Journal. 347: 829-36. PMID 10769189 DOI: 10.1042/Bj3470829 |
0.697 |
|
| 2000 |
Kraus RL, Sinnegger MJ, Koschak A, Glossmann H, Stenirri S, Carrera P, Striessnig J. Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. The Journal of Biological Chemistry. 275: 9239-43. PMID 10734061 DOI: 10.1074/Jbc.275.13.9239 |
0.648 |
|
| 1999 |
Wanner SG, Glossmann H, Knaus HG, Baker R, Parsons W, Rupprecht KM, Brochu R, Cohen CJ, Schmalhofer W, Smith M, Warren V, Garcia ML, Kaczorowski GJ. WIN 17317-3, a new high-affinity probe for voltage-gated sodium channels. Biochemistry. 38: 11137-46. PMID 10460170 DOI: 10.1021/Bi990336P |
0.501 |
|
| 1999 |
Berjukow S, Gapp F, Aczél S, Sinnegger MJ, Mitterdorfer J, Glossmann H, Hering S. Sequence differences between alpha1C and alpha1S Ca2+ channel subunits reveal structural determinants of a guarded and modulated benzothiazepine receptor. The Journal of Biological Chemistry. 274: 6154-60. PMID 10037699 DOI: 10.1074/Jbc.274.10.6154 |
0.554 |
|
| 1999 |
Moebius FF, Soellner KE, Fiechtner B, Huck CW, Bonn G, Glossmann H. Histidine77, glutamic acid81, glutamic acid123, threonine126, asparagine194, and tryptophan197 of the human emopamil binding protein are required for in vivo sterol delta 8-delta 7 isomerization. Biochemistry. 38: 1119-27. PMID 9894009 DOI: 10.1021/Bi981804I |
0.351 |
|
| 1998 |
Mitterdorfer J, Grabner M, Kraus RL, Hering S, Prinz H, Glossmann H, Striessnig J. Molecular basis of drug interaction with L-type Ca2+ channels. Journal of Bioenergetics and Biomembranes. 30: 319-34. PMID 9758329 DOI: 10.1023/A:1021933504909 |
0.743 |
|
| 1998 |
Striessnig J, Grabner M, Mitterdorfer J, Hering S, Sinnegger MJ, Glossmann H. Structural basis of drug binding to L Ca2+ channels. Trends in Pharmacological Sciences. 19: 108-15. PMID 9584627 DOI: 10.1016/S0165-6147(98)01171-7 |
0.754 |
|
| 1998 |
Neuhuber B, Gerster U, Döring F, Glossmann H, Tanabe T, Flucher BE. Association of calcium channel alpha1S and beta1a subunits is required for the targeting of beta1a but not of alpha1S into skeletal muscle triads. Proceedings of the National Academy of Sciences of the United States of America. 95: 5015-20. PMID 9560220 DOI: 10.1073/Pnas.95.9.5015 |
0.671 |
|
| 1998 |
Neuhuber B, Gerster U, Mitterdorfer J, Glossmann H, Flucher BE. Differential effects of Ca2+ channel beta1a and beta2a subunits on complex formation with alpha1S and on current expression in tsA201 cells. The Journal of Biological Chemistry. 273: 9110-8. PMID 9535900 DOI: 10.1074/Jbc.273.15.9110 |
0.616 |
|
| 1998 |
Kraus RL, Sinnegger MJ, Glossmann H, Hering S, Striessnig J. Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. The Journal of Biological Chemistry. 273: 5586-90. PMID 9488686 DOI: 10.1074/Jbc.273.10.5586 |
0.585 |
|
| 1997 |
Sinnegger MJ, Wang Z, Grabner M, Hering S, Striessnig J, Glossmann H, Mitterdorfer J. Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188. The Journal of Biological Chemistry. 272: 27686-93. PMID 9346909 DOI: 10.1074/Jbc.272.44.27686 |
0.757 |
|
| 1997 |
Moebius FF, Reiter RJ, Hanner M, Glossmann H. High affinity of sigma 1-binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase. British Journal of Pharmacology. 121: 1-6. PMID 9146879 DOI: 10.1038/Sj.Bjp.0701079 |
0.356 |
|
| 1997 |
Moebius FF, Striessnig J, Glossmann H. The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends in Pharmacological Sciences. 18: 67-70. PMID 9133773 DOI: 10.1016/S0165-6147(96)01037-1 |
0.489 |
|
| 1997 |
Brauns T, Prinz H, Kimball SD, Haugland RP, Striessnig J, Glossmann H. L-type calcium channels: binding domains for dihydropyridines and benzothiazepines are located in close proximity to each other. Biochemistry. 36: 3625-31. PMID 9132014 DOI: 10.1021/Bi9613584 |
0.634 |
|
| 1997 |
Hinterdorfer P, Gruber HJ, Striessnig J, Glossmann H, Schindler H. Analysis of membrane protein self-association in lipid systems by fluorescence particle counting: application to the dihydropyridine receptor. Biochemistry. 36: 4497-504. PMID 9109657 DOI: 10.1021/Bi962009C |
0.5 |
|
| 1996 |
Moebius FF, Bermoser K, Reiter RJ, Hanner M, Glossmann H. Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors. Biochemistry. 35: 16871-8. PMID 8988026 DOI: 10.1021/Bi961996M |
0.369 |
|
| 1996 |
Mitterdorfer J, Wang Z, Sinnegger MJ, Hering S, Striessnig J, Grabner M, Glossmann H. Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity. The Journal of Biological Chemistry. 271: 30330-5. PMID 8939992 DOI: 10.1074/Jbc.271.48.30330 |
0.757 |
|
| 1996 |
Pichler M, Wang Z, Grabner-Weiss C, Reimer D, Hering S, Grabner M, Glossmann H, Striessnig J. Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics. Biochemistry. 35: 14659-64. PMID 8931565 DOI: 10.1021/Bi961657T |
0.736 |
|
| 1996 |
Hering S, Aczél S, Grabner M, Döring F, Berjukow S, Mitterdorfer J, Sinnegger MJ, Striessnig J, Degtiar VE, Wang Z, Glossmann H. Transfer of high sensitivity for benzothiazepines from L-type to class A (BI) calcium channels. The Journal of Biological Chemistry. 271: 24471-5. PMID 8798706 DOI: 10.1074/Jbc.271.40.24471 |
0.722 |
|
| 1996 |
Berjukow S, Döring F, Froschmayr M, Grabner M, Glossmann H, Hering S. Endogenous calcium channels in human embryonic kidney (HEK293) cells. British Journal of Pharmacology. 118: 748-54. PMID 8762103 DOI: 10.1111/J.1476-5381.1996.Tb15463.X |
0.615 |
|
| 1996 |
Mitterdorfer J, Froschmayr M, Grabner M, Moebius FF, Glossmann H, Striessnig J. Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits. Biochemistry. 35: 9400-6. PMID 8755718 DOI: 10.1021/Bi960683O |
0.727 |
|
| 1996 |
Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, Glossmann H. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proceedings of the National Academy of Sciences of the United States of America. 93: 8072-7. PMID 8755605 DOI: 10.1073/Pnas.93.15.8072 |
0.542 |
|
| 1996 |
Boer R, Dichtl M, Borchers C, Ulrich WR, Marecek JF, Prestwich GD, Glossmann H, Striessnig J. Reversible labeling of a chemosensitizer binding domain of p-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor. Biochemistry. 35: 1387-96. PMID 8634268 DOI: 10.1021/Bi951912U |
0.569 |
|
| 1996 |
Grabner M, Wang Z, Hering S, Striessnig J, Glossmann H. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron. 16: 207-18. PMID 8562085 DOI: 10.1016/S0896-6273(00)80037-9 |
0.753 |
|
| 1995 |
Brauns T, Cai ZW, Kimball SD, Kang KC, Haugland RP, Berger W, Berjukov S, Hering S, Glossmann H, Striessnig J. Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue. Biochemistry. 34: 3461-9. PMID 7880840 |
0.636 |
|
| 1995 |
Kwan YW, Bangalore R, Lakitsh M, Glossmann H, Kass RS. Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implications for pharmacokinetics and access to dihydropyridine binding site. Journal of Molecular and Cellular Cardiology. 27: 253-62. PMID 7760349 DOI: 10.1016/S0022-2828(08)80024-7 |
0.456 |
|
| 1995 |
Hanner M, Moebius FF, Weber F, Grabner M, Striessnig J, Glossmann H. Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. The Journal of Biological Chemistry. 270: 7551-7. PMID 7706302 DOI: 10.1074/Jbc.270.13.7551 |
0.69 |
|
| 1995 |
Mitterdorfer J, Sinnegger MJ, Grabner M, Striessnig J, Glossmann H. Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit. Biochemistry. 34: 9350-5. PMID 7626604 DOI: 10.1021/Bi00029A010 |
0.741 |
|
| 1995 |
Wang Z, Grabner M, Berjukow S, Savchenko A, Glossmann H, Hering S. Chimeric L-type Ca2+ channels expressed in Xenopus laevis oocytes reveal role of repeats III and IV in activation gating. The Journal of Physiology. 486: 131-7. PMID 7562629 DOI: 10.1113/Jphysiol.1995.Sp020797 |
0.573 |
|
| 1995 |
Savchenko A, Glossmann H, Hering S. Improved micro-perfusion chamber for multiple and rapid solution exchange in adherent single cells. Pflã¼Gers Archiv : European Journal of Physiology. 429: 436-42. PMID 7539128 DOI: 10.1007/Bf00374161 |
0.335 |
|
| 1994 |
Grabner M, Bachmann A, Rosenthal F, Striessnig J, Schultz C, Tautz D, Glossmann H. Insect calcium channels. Molecular cloning of an alpha 1-subunit from housefly (Musca domestica) muscle. Febs Letters. 339: 189-94. PMID 8313972 DOI: 10.1016/0014-5793(94)80413-3 |
0.73 |
|
| 1994 |
Grabner M, Wang Z, Mitterdorfer J, Rosenthal F, Charnet P, Savchenko A, Hering S, Ren D, Hall LM, Glossmann H. Cloning and functional expression of a neuronal calcium channel beta subunit from house fly (Musca domestica). The Journal of Biological Chemistry. 269: 23668-74. PMID 8089136 |
0.518 |
|
| 1994 |
Moebius FF, Hanner M, Knaus HG, Weber F, Striessnig J, Glossmann H. Purification and amino-terminal sequencing of the high affinity phenylalkylamine Ca2+ antagonist binding protein from guinea pig liver endoplasmic reticulum. The Journal of Biological Chemistry. 269: 29314-20. PMID 7961902 |
0.549 |
|
| 1994 |
Mitterdorfer J, Froschmayr M, Grabner M, Striessnig J, Glossmann H. Calcium channels: the beta-subunit increases the affinity of dihydropyridine and Ca2+ binding sites of the alpha 1-subunit. Febs Letters. 352: 141-5. PMID 7925963 DOI: 10.1016/0014-5793(94)00938-4 |
0.747 |
|
| 1994 |
Berger W, Prinz H, Striessnig J, Kang HC, Haugland R, Glossmann H. Complex molecular mechanism for dihydropyridine binding to L-type Ca(2+)-channels as revealed by fluorescence resonance energy transfer. Biochemistry. 33: 11875-83. PMID 7918406 DOI: 10.1021/Bi00205A025 |
0.643 |
|
| 1994 |
Knaus HG, Eberhart A, Glossmann H, Munujos P, Kaczorowski GJ, Garcia ML. Pharmacology and structure of high conductance calcium-activated potassium channels. Cellular Signalling. 6: 861-70. PMID 7718406 DOI: 10.1016/0898-6568(94)90019-1 |
0.443 |
|
| 1993 |
Moebius FF, Burrows GG, Striessnig J, Glossmann H. Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action. Molecular Pharmacology. 43: 139-48. PMID 8429820 |
0.549 |
|
| 1993 |
Glossmann H, Hering S, Savchenko A, Berger W, Friedrich K, Garcia ML, Goetz MA, Liesch JM, Zink DL, Kaczorowski GJ. A light stabilizer (Tinuvin 770) that elutes from polypropylene plastic tubes is a potent L-type Ca(2+)-channel blocker. Proceedings of the National Academy of Sciences of the United States of America. 90: 9523-7. PMID 8415734 DOI: 10.1073/Pnas.90.20.9523 |
0.536 |
|
| 1993 |
Lakitsch M, Knaus HG, Topar G, Romanin C, Boer R, Flockerzi D, Striessnig J, Schindler H, Hoeltje HD, Glossmann H. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67. Molecular Pharmacology. 43: 293-301. PMID 8381514 |
0.646 |
|
| 1993 |
Moebius FF, Burrows GG, Hanner M, Schmid E, Striessnig J, Glossmann H. Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies. Molecular Pharmacology. 44: 966-71. PMID 8246920 |
0.545 |
|
| 1993 |
Strübing C, Hering S, Glossmann H. Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels. British Journal of Pharmacology. 108: 884-91. PMID 7683566 DOI: 10.1111/j.1476-5381.1993.tb13482.x |
0.381 |
|
| 1993 |
Eismann E, Bönigk W, Kaupp B, Macdonald RL, Angelotti TP, Paulmichl M, Gschwentner M, Wöll E, Schmarda A, Ritter M, Kanin G, Ellemunter H, Waitz W, Deetjen P, Carroll TP, ... ... Glossmann H, et al. Subject Index, Vol. 3, 1993 Cellular Physiology and Biochemistry. 3: 401-402. DOI: 10.1159/000154702 |
0.451 |
|
| 1993 |
Striessnig J, Berger W, Glossmann H. Molecular properties of voltage-dependent ca2+ channels in excitable tissues Cellular Physiology and Biochemistry. 3: 295-317. DOI: 10.1159/000154695 |
0.681 |
|
| 1993 |
Eismann E, Bönigk W, Kaupp B, Macdonald RL, Angelotti TP, Paulmichl M, Gschwentner M, Wöll E, Schmarda A, Ritter M, Kanin G, Ellemunter H, Waitz W, Deetjen P, Carroll TP, ... ... Glossmann H, et al. Contents, Vol. 3, 1993 Cellular Physiology and Biochemistry. 3. DOI: 10.1159/000154687 |
0.449 |
|
| 1992 |
Romanin C, Seydl K, Glossmann H, Schindler H. The dihydropyridine niguldipine inhibits T-type Ca2+ currents in atrial myocytes. Pflã¼Gers Archiv : European Journal of Physiology. 420: 410-2. PMID 1598197 DOI: 10.1007/Bf00374478 |
0.373 |
|
| 1992 |
Knaus HG, Moshammer T, Friedrich K, Kang HC, Haugland RP, Glossmann H. In vivo labeling of L-type Ca2+ channels by fluorescent dihydropyridines: Evidence for a functional, extracellular heparin-binding site Proceedings of the National Academy of Sciences of the United States of America. 89: 3586-3590. PMID 1314393 |
0.413 |
|
| 1992 |
Knaus HG, Striessnig J, Hering S, Marrer S, Schwenner E, Höltje HD, Glossmann H. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties. Molecular Pharmacology. 41: 298-307. PMID 1311409 |
0.677 |
|
| 1992 |
Knaus HG, Moshammer T, Kang HC, Haugland RP, Glossmann H. A unique fluorescent phenylalkylamine probe for L-type Ca2+ channels. Coupling of phenylalkylamine receptors to Ca2+ and dihydropyridine binding sites. The Journal of Biological Chemistry. 267: 2179-89. PMID 1310311 |
0.455 |
|
| 1992 |
Striessnig J, Glossmann H. L-type calcium channels and calcium channel ligands Pharmacochemistry Library. 18: 333-343. DOI: 10.1016/B978-0-444-88931-7.50024-4 |
0.701 |
|
| 1991 |
Glossmann H, Zech C, Striessnig J, Staudinger R, Hall L, Greenberg R, Armah BI. Very high affinity interaction of DPI 201-106 and BDF 8784 enantiomers with the phenylalkylamine-sensitive Ca2(+)-channel in Drosophila head membranes. British Journal of Pharmacology. 102: 446-52. PMID 1849770 DOI: 10.1111/J.1476-5381.1991.Tb12193.X |
0.691 |
|
| 1991 |
Grabner M, Friedrich K, Knaus HG, Striessnig J, Scheffauer F, Staudinger R, Koch WJ, Schwartz A, Glossmann H. Calcium channels from Cyprinus carpio skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America. 88: 727-31. PMID 1846962 DOI: 10.1073/Pnas.88.3.727 |
0.737 |
|
| 1991 |
Zech C, Staudinger R, Mühlbacher J, Glossmann H. Novel sites for phenylalkylamines: characterisation of a sodium-sensitive drug receptor with (-)-[3H]emopamil. European Journal of Pharmacology. 208: 119-30. PMID 1800125 DOI: 10.1016/0922-4106(91)90062-M |
0.453 |
|
| 1991 |
Himmel HM, Glossmann H, Ravens U. Naftopidil, a new alpha-adrenoceptor blocking agent with calcium antagonistic properties: characterization of Ca2+ antagonistic effects. Journal of Cardiovascular Pharmacology. 17: 213-21. PMID 1709225 DOI: 10.1097/00005344-199102000-00006 |
0.453 |
|
| 1991 |
Nakayama H, Taki M, Striessnig J, Glossmann H, Catterall WA, Kanaoka Y. Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine. Proceedings of the National Academy of Sciences of the United States of America. 88: 9203-7. PMID 1656465 |
0.635 |
|
| 1991 |
Haase H, Striessnig J, Holtzhauer M, Vetter R, Glossmann H. A rapid procedure for the purification of cardiac 1,4-dihydropyridine receptors from porcine heart. European Journal of Pharmacology. 207: 51-9. PMID 1655494 DOI: 10.1016/S0922-4106(05)80037-9 |
0.63 |
|
| 1991 |
Staudinger R, Knaus HG, Glossmann H. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140. The Journal of Biological Chemistry. 266: 10787-95. PMID 1645709 |
0.418 |
|
| 1991 |
Striessnig J, Glossmann H. [14] - Purification of L-Type Calcium Channel Drug Receptors Methods in Neurosciences. 4: 210-229. DOI: 10.1016/B978-0-12-185257-3.50019-7 |
0.642 |
|
| 1990 |
Striessnig J, Glossmann H, Catterall WA. Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels. Proceedings of the National Academy of Sciences of the United States of America. 87: 9108-12. PMID 2174553 DOI: 10.1073/Pnas.87.23.9108 |
0.665 |
|
| 1990 |
Knaus HG, Scheffauer F, Romanin C, Schindler HG, Glossmann H. Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action. The Journal of Biological Chemistry. 265: 11156-66. PMID 2162834 |
0.48 |
|
| 1990 |
Glossmann H, Striessnig J. Molecular properties of calcium channels. Reviews of Physiology, Biochemistry and Pharmacology. 114: 1-105. PMID 2155469 DOI: 10.1007/Bfb0031018 |
0.587 |
|
| 1990 |
Striessnig J, Scheffauer F, Mitterdorfer J, Schirmer M, Glossmann H. Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with (+)-cis-azidodiltiazem and anti-ligand antibodies. The Journal of Biological Chemistry. 265: 363-70. PMID 2152924 |
0.634 |
|
| 1990 |
Glossmann H. New therapeutic uses of calcium channel blockers. Introduction. Journal of Neural Transmission. Supplementum. 31: 1-3. PMID 2074435 |
0.335 |
|
| 1990 |
Zernig G, Graziadei I, Moshammer T, Zech C, Reider N, Glossmann H. Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channel. Molecular Pharmacology. 38: 362-9. PMID 1698252 |
0.34 |
|
| 1989 |
Grassegger A, Striessnig J, Weiler M, Knaus HG, Glossmann H. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain. Naunyn-Schmiedeberg's Archives of Pharmacology. 340: 752-9. PMID 2561307 DOI: 10.1007/Bf00169685 |
0.693 |
|
| 1989 |
Graziadei I, Zernig G, Grassegger A, Boer R, Schudt C, Glossmann H. Hydrophobic calcium channel ligands: methodical problems and their solution. The American Journal of Cardiology. 64: 43I-50I. PMID 2554713 DOI: 10.1016/0002-9149(89)90959-4 |
0.419 |
|
| 1989 |
Boer R, Grassegger A, Schudt C, Glossmann H. (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors. European Journal of Pharmacology. 172: 131-45. PMID 2548881 DOI: 10.1016/0922-4106(89)90004-7 |
0.358 |
|
| 1989 |
Glossmann H, Striessnig J, Knaus HG, Müller J, Grassegger A, Höltje HD, Marrer S, Hymel L, Schindler HG. Structure of calcium channels. Annals of the New York Academy of Sciences. 560: 198-214. PMID 2545133 DOI: 10.1111/J.1749-6632.1989.Tb24098.X |
0.585 |
|
| 1989 |
Greenberg RM, Striessnig J, Koza A, Devay P, Glossmann H, Hall LM. Native and detergent-solubilized membrane extracts from Drosophila heads contain binding sites for phenylalkylamine calcium channel blockers Insect Biochemistry. 19: 309-322. DOI: 10.1016/0020-1790(89)90077-2 |
0.615 |
|
| 1989 |
Hymel L, Schindler H, Inui M, Fleischer S, Striessnig J, Glossmann H. A molecular model of excitation - contraction coupling at the skeletal muscle triad junction via coassociated oligomeric calcium channels Annals of the New York Academy of Sciences. 560: 185-188. |
0.566 |
|
| 1988 |
Zernig G, Glossmann H. A novel 1,4-dihydropyridine-binding site on mitochondrial membranes from guinea-pig heart, liver and kidney. The Biochemical Journal. 253: 49-58. PMID 3421952 |
0.352 |
|
| 1988 |
Glossmann H, Striessnig J. Calcium channels. Vitamins and Hormones. 44: 155-328. PMID 2853487 |
0.594 |
|
| 1988 |
Zernig G, Moshammer T, Graziadei I, Glossmann H. The mitochondrial high-capacity low-affinity (+/-)-[3H]nitrendipine binding site is regulated by nucleotides. European Journal of Pharmacology. 157: 67-73. PMID 2853075 DOI: 10.1016/0014-2999(88)90472-4 |
0.363 |
|
| 1988 |
Striessnig J, Knaus HG, Glossmann H. Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel. The Biochemical Journal. 253: 39-47. PMID 2844171 DOI: 10.1042/Bj2530039 |
0.678 |
|
| 1988 |
Striessnig J, Meusburger E, Grabner M, Knaus HG, Glossmann H, Kaiser J, Schölkens B, Becker R, Linz W, Henning R. Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166. Naunyn-Schmiedeberg's Archives of Pharmacology. 337: 331-40. PMID 2839780 DOI: 10.1007/Bf00168847 |
0.735 |
|
| 1988 |
Hymel L, Striessnig J, Glossmann H, Schindler H. Purified skeletal muscle 1,4-dihydropyridine receptor forms phosphorylation-dependent oligomeric calcium channels in planar bilayers. Proceedings of the National Academy of Sciences of the United States of America. 85: 4290-4. PMID 2454467 DOI: 10.1073/Pnas.85.12.4290 |
0.691 |
|
| 1988 |
Glossmann H, Striessnig J, Hymel L, Schindler H. Purification and reconstitution of calcium channel drug-receptor sites. Annals of the New York Academy of Sciences. 522: 150-61. PMID 2454049 DOI: 10.1111/J.1749-6632.1988.Tb33351.X |
0.612 |
|
| 1988 |
Zernig G, Moshammer T, Glossmann H. Phosphatidylinositol turnover as a functional probe for neuronal Ca2+ channels. Progress in Clinical and Biological Research. 252: 41-5. PMID 2450375 |
0.303 |
|
| 1988 |
Striessnig J, Glossmann H. Characterization of the drug receptors of the purified skeletal muscle calcium channel. Progress in Clinical and Biological Research. 252: 35-40. PMID 2450374 |
0.601 |
|
| 1988 |
Glossmann H, Striessnig J, Knaus H, Müller J, Zernig G, Moshammer T, Grassegger A. Radiochemicals in the study of receptors International Journal of Radiation Applications and Instrumentation. Part a. Applied Radiation and Isotopes. 39: 505. DOI: 10.1016/0883-2889(88)90201-8 |
0.618 |
|
| 1988 |
Glossmann H, Striessnig J. Structure and pharmacology of voltage-dependent calcium channels Isi Atlas of Science: Pharmacology. 2: 202-210. |
0.589 |
|
| 1987 |
Knaus HG, Striessnig J, Koza A, Glossmann H. Neurotoxic aminoglycoside antibiotics are potent inhibitors of [125I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes. Naunyn-Schmiedeberg's Archives of Pharmacology. 336: 583-6. PMID 2830547 DOI: 10.1007/Bf00169318 |
0.66 |
|
| 1987 |
Glossmann H, Striessnig J, Hymel L, Schindler H. Purified L-type calcium channels: only one single polypeptide (alpha 1-subunit) carries the drug receptor domains and is regulated by protein kinases. Biomedica Biochimica Acta. 46: S351-6. PMID 2449181 |
0.651 |
|
| 1987 |
Vaghy PL, Striessnig J, Miwa K, Knaus HG, Itagaki K, McKenna E, Glossmann H, Schwartz A. Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations. The Journal of Biological Chemistry. 262: 14337-42. PMID 2443504 |
0.622 |
|
| 1987 |
Glossmann H, Striessnig J, Ferry DR, Goll A, Moosburger K, Schirmer M. Interaction between calcium channel ligands and calcium channels. Circulation Research. 61: I30-6. PMID 2443273 |
0.646 |
|
| 1987 |
Ferry DR, Goll A, Glossmann H. Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand. The Biochemical Journal. 243: 127-35. PMID 2440422 DOI: 10.1042/Bj2430127 |
0.494 |
|
| 1987 |
Striessnig J, Knaus HG, Grabner M, Moosburger K, Seitz W, Lietz H, Glossmann H. Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel. Febs Letters. 212: 247-53. PMID 2434359 DOI: 10.1016/0014-5793(87)81354-6 |
0.743 |
|
| 1987 |
Glossmann H, Ferry DR, Striessnig J, Goll A, Moosburger K. Resolving the structure of the Ca2+ channel by photoaffinity labelling Trends in Pharmacological Sciences. 8: 95-100. DOI: 10.1016/0165-6147(87)90082-4 |
0.678 |
|
| 1986 |
Zernig G, Moshammer T, Glossmann H. Stereospecific regulation of [3H]inositol monophosphate accumulation by calcium channel drugs from all three main chemical classes. European Journal of Pharmacology. 128: 221-9. PMID 3098571 DOI: 10.1016/0014-2999(86)90769-7 |
0.467 |
|
| 1986 |
Goll A, Glossmann H, Mannhold R. Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart. Naunyn-Schmiedeberg's Archives of Pharmacology. 334: 303-12. PMID 3027587 DOI: 10.1007/BF00508786 |
0.332 |
|
| 1986 |
Striessnig J, Moosburger K, Goll A, Ferry DR, Glossmann H. Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel. European Journal of Biochemistry / Febs. 161: 603-9. PMID 2431906 DOI: 10.1111/J.1432-1033.1986.Tb10484.X |
0.648 |
|
| 1986 |
Seagar MJ, Labbé-Jullié C, Granier C, Goll A, Glossmann H, Van Rietschoten J, Couraud F. Molecular structure of rat brain apamin receptor: differential photoaffinity labeling of putative K+ channel subunits and target size analysis. Biochemistry. 25: 4051-7. PMID 2427110 DOI: 10.1021/Bi00362A010 |
0.454 |
|
| 1986 |
Striessnig J, Goll A, Moosburger K, Glossmann H. Purified calcium channels have three allosterically coupled drug receptors. Febs Letters. 197: 204-10. PMID 2419161 DOI: 10.1016/0014-5793(86)80327-1 |
0.696 |
|
| 1985 |
Striessnig J, Zernig G, Glossmann H. Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter. European Journal of Biochemistry / Febs. 150: 67-77. PMID 2990927 DOI: 10.1111/J.1432-1033.1985.Tb08989.X |
0.618 |
|
| 1985 |
Glossmann H, Baukal A, Aguilera G, Catt KJ. Radioligand assay for angiotensin II receptors. Methods in Enzymology. 109: 110-26. PMID 2985913 DOI: 10.1016/0076-6879(85)09080-2 |
0.327 |
|
| 1985 |
Striessnig J, Zernig G, Glossmann H. Ca2+ antagonist receptor sites on human red blood cell membranes. European Journal of Pharmacology. 108: 329-30. PMID 2985404 DOI: 10.1016/0014-2999(85)90460-1 |
0.56 |
|
| 1985 |
Glossmann H, Ferry DR. Assay for calcium channels. Methods in Enzymology. 109: 513-50. PMID 2581112 DOI: 10.1016/0076-6879(85)09112-1 |
0.532 |
|
| 1985 |
Glossmann H, Ferry DR, Goll A, Linn T. Molecular approach to the calcium channel. Advances in Myocardiology. 5: 41-76. PMID 2578683 |
0.445 |
|
| 1985 |
Glossmann H. Activation of chromaffin cell Ca2+ channels by novel dihydropyridine. Nature. 313: 503-4. PMID 2578625 DOI: 10.1038/313503c0 |
0.343 |
|
| 1985 |
Glossmann H, Ferry DR, Goll A, Striessnig J, Zernig G. Calcium channels and calcium channel drugs: recent biochemical and biophysical findings. Arzneimittel-Forschung. 35: 1917-35. PMID 2420337 |
0.635 |
|
| 1985 |
Ferry DR, Kämpf K, Goll A, Glossmann H. Subunit composition of skeletal muscle transverse tubule calcium channels evaluated with the 1,4-dihydropyridine photoaffinity probe, [3H]azidopine. The Embo Journal. 4: 1933-40. PMID 2415355 |
0.38 |
|
| 1985 |
Glossmann H, Ferry DR, Goll A, Striessnig J, Schober M. Calcium channels: basic properties as revealed by radioligand binding studies. Journal of Cardiovascular Pharmacology. 7: S20-30. PMID 2414589 |
0.659 |
|
| 1985 |
Ferry DR, Goll A, Rombusch M, Glossmann H. The molecular pharmacology and structural features of calcium channels. British Journal of Clinical Pharmacology. 20: 233S-246S. PMID 2413875 DOI: 10.1111/j.1365-2125.1985.tb02809.x |
0.325 |
|
| 1985 |
Ferry DR, Glossmann H, Kaumann AJ. Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart. British Journal of Pharmacology. 84: 811-24. PMID 2408698 |
0.38 |
|
| 1984 |
Goll A, Ferry DR, Glossmann H. Target size analysis and molecular properties of Ca2+ channels labelled with [3H]verapamil. European Journal of Biochemistry / Febs. 141: 177-86. PMID 6327306 DOI: 10.1111/J.1432-1033.1984.Tb08172.X |
0.497 |
|
| 1984 |
Ferry DR, Glossmann H. 125I-iodipine, a new high affinity ligand for the putative calcium channel. Naunyn-Schmiedeberg's Archives of Pharmacology. 325: 186-9. PMID 6325952 DOI: 10.1007/BF00506200 |
0.415 |
|
| 1984 |
Ferry DR, Rombush M, Goll A, Glossmann H. Photoaffinity labelling of Ca2+ channels with [3H]azidopine. Febs Letters. 169: 112-8. PMID 6325234 DOI: 10.1016/0014-5793(84)80299-9 |
0.398 |
|
| 1984 |
Glossmann H, Goll A, Ferry DR, Rombusch M. The identification of cytoplasmic membrane calcium-entry channels by ligand-binding studies. Biochemical Society Transactions. 12: 941-3. PMID 6099291 |
0.375 |
|
| 1984 |
Ferry DR, Goll A, Gadow C, Glossmann H. (-)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites. Naunyn-Schmiedeberg's Archives of Pharmacology. 327: 183-7. PMID 6092974 DOI: 10.1007/BF00500915 |
0.383 |
|
| 1984 |
Goll A, Ferry DR, Striessnig J, Schober M, Glossmann H. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle. Febs Letters. 176: 371-7. PMID 6092142 DOI: 10.1016/0014-5793(84)81199-0 |
0.659 |
|
| 1984 |
Glossmann H, Ferry DR, Goll A, Rombusch M. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine. Journal of Cardiovascular Pharmacology. 6: S608-21. PMID 6083403 |
0.454 |
|
| 1983 |
Ferry DR, Goll A, Glossmann H. Calcium channels: evidence for oligomeric nature by target size analysis. The Embo Journal. 2: 1729-32. PMID 6315398 |
0.406 |
|
| 1983 |
Ferry DR, Goll A, Glossmann H. Putative calcium channel molecular weight determination by target size analysis. Naunyn-Schmiedeberg's Archives of Pharmacology. 323: 292-7. PMID 6314150 DOI: 10.1007/BF00512466 |
0.33 |
|
| 1983 |
Glossmann H, Ferry DR. Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine. Naunyn-Schmiedeberg's Archives of Pharmacology. 323: 279-91. PMID 6314149 DOI: 10.1007/BF00512465 |
0.453 |
|
| 1983 |
Ferry DR, Goll A, Glossmann H. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110. Naunyn-Schmiedeberg's Archives of Pharmacology. 323: 276-7. PMID 6312337 DOI: 10.1007/Bf00497674 |
0.498 |
|
| 1983 |
Glossmann H, Linn T, Rombusch M, Ferry DR. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists. Febs Letters. 160: 226-32. PMID 6309565 DOI: 10.1016/0014-5793(83)80972-7 |
0.42 |
|
| 1983 |
Glossmann H, Ferry DR, Boschek CB. Purification of the putative calcium channel from skeletal muscle with the aid of [3H]-nimodipine binding. Naunyn-Schmiedeberg's Archives of Pharmacology. 323: 1-11. PMID 6308477 DOI: 10.1007/BF00498821 |
0.384 |
|
| 1983 |
Goll A, Ferry DR, Glossmann H. Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation. Febs Letters. 157: 63-9. PMID 6305718 DOI: 10.1016/0014-5793(83)81117-X |
0.486 |
|
| 1983 |
Glossmann H, Ferry DR, Lübbecke F, Mewes R, Hofmann F. Identification of voltage operated calcium channels by binding studies: differentiation of subclasses of calcium antagonist drugs with 3H-nimodipine radioligand binding. Journal of Receptor Research. 3: 177-90. PMID 6304295 DOI: 10.3109/10799898309041932 |
0.454 |
|
| 1983 |
Ferry DR, Glossmann H. Tissue specific regulation of (3H) nimodipine binding to putative calcium channels by the biologically active isomer of diltiazem British Journal of Pharmacology. 78. |
0.368 |
|
| 1982 |
Bellemann P, Ferry D, Lübbecke F, Glossmann H. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength. Arzneimittel-Forschung. 32: 361-3. PMID 7201804 |
0.32 |
|
| 1982 |
Ferry DR, Glossmann H. Identification of putative calcium channels in skeletal muscle microsomes. Febs Letters. 148: 331-7. PMID 6295810 DOI: 10.1016/0014-5793(82)80835-1 |
0.381 |
|
| 1982 |
Schwabe U, Lenschow V, Ukena D, Ferry DR, Glossmann H. [125I] N6-p-Hydroxyphenylisopropyladenosine, a new ligand for Ri adenosine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 321: 84-7. PMID 6292745 DOI: 10.1007/Bf00586356 |
0.381 |
|
| 1982 |
Ferry DR, Glossmann H. Evidence of multiple receptor sites within the putative calcium channel. Naunyn-Schmiedeberg's Archives of Pharmacology. 321: 80-3. PMID 6292744 DOI: 10.1007/Bf00586355 |
0.518 |
|
| 1982 |
Glossmann H, Lübbecke F. [125I]-HEAT:fifty percent of the ligand can bind to the alpha1-adrenoceptors with extremely high affinity. Naunyn-Schmiedeberg's Archives of Pharmacology. 321: 7-10. PMID 6292742 DOI: 10.1007/Bf00586341 |
0.371 |
|
| 1982 |
Glossmann H, Lübbecke F, Bellemann P, Sattler EL, Doell G. Ionic modulation of alpha-adrenoceptors. Journal of Cardiovascular Pharmacology. 4: S51-7. PMID 6175845 DOI: 10.1097/00005344-198200041-00011 |
0.395 |
|
| 1982 |
Glossmann H, Ferry DR, Lübbecke F, Mewes R, Hofmann F. Calcium channels: direct identification with radioligand binding studies Trends in Pharmacological Sciences. 3: 431-437. DOI: 10.1016/0165-6147(82)91221-4 |
0.395 |
|
| 1981 |
Bonacker O, Glossmann H. Mammalian beta-adrenoceptors: concomitant biospecific elution with protein kinase activity from Sepharose-alprenolol. European Journal of Pharmacology. 75: 197-204. PMID 6274666 DOI: 10.1016/0014-2999(81)90545-8 |
0.325 |
|
| 1981 |
Glossmann H, Lübbecke F, Bellemann P, Presek P. Cation sensitivity of [125I]heat binding to alpha 1-adrenoceptors in rat cerebral cortex membranes. European Journal of Pharmacology. 75: 149-53. PMID 6119216 DOI: 10.1016/0014-2999(81)90076-5 |
0.368 |
|
| 1980 |
Glossmann H, Hornung R. Alpha 2 adrenoceptors in rat brain: the divalent cation site. Naunyn-Schmiedeberg's Archives of Pharmacology. 314: 101-9. PMID 6256664 DOI: 10.1007/Bf00504525 |
0.338 |
|
| 1980 |
Glossmann H, Hornung R. Calcium- and potassium-channel blockers interact with alpha-adrenoceptors. Molecular and Cellular Endocrinology. 19: 243-51. PMID 6250930 DOI: 10.1016/0303-7207(80)90054-4 |
0.451 |
|
| 1980 |
Glossmann H, Hornung R, Schlusche R. Sodium ions increase the affinity of clonidine for α1-adrenoceptors in rat brain Naunyn-Schmiedeberg's Archives of Pharmacology. 312: 105-106. PMID 6250084 DOI: 10.1007/Bf00569717 |
0.352 |
|
| 1980 |
Glossmann H, Hornung R. alpha-Adrenoceptors in rat brain: sodium changes the affinity of agonists for prazosin sites. European Journal of Pharmacology. 61: 407-8. PMID 6245895 DOI: 10.1016/0014-2999(80)90083-7 |
0.337 |
|
| 1973 |
Glossmann H, Neville DM. Phlorizin receptors in isolated kidney brush border membranes. Differential enzymatic modification of high-affinity receptors and unspecific binding sites. Biochimica Et Biophysica Acta. 323: 408-14. PMID 4757318 DOI: 10.1016/0005-2736(73)90186-7 |
0.331 |
|
| Show low-probability matches. |